Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Saime Sürmen"'
Autor:
Saime Sürmen, Soykan Arıkan, Özlem Timirci Kahraman, Mustafa Gani Sürmen, Canan Cacina, İlhan Yaylım
Publikováno v:
Experimed. 12:119-124
Autor:
Mustafa Gani Sürmen, Tijen Alkan Bozkaya, Mehmet Ateş, Saime Sürmen, Çağrı Çakıcı, Sadrettin Pençe, Nesrin Emekli
Objective: Type 2 diabetes mellitus (T2D) is a metabolic disease whose molecular events have not yet been fully clarified. However, next-generation powerful molecular approaches such as mass spectrometry (MS)-based proteomics holds promise. In this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccfabf7b2e6e9e3f3626f0c41474aafb
https://hdl.handle.net/20.500.12511/11038
https://hdl.handle.net/20.500.12511/11038
Autor:
İsmail Ünal, Derya Cansız, Mustafa Gani Sürmen, Saime Sürmen, Zehra Sezer, Merih Beler, Ünsal Veli Üstündağ, Elif Güzel, A. Ata Alturfan, Ebru Emekli‐Alturfan
Disruption of the gut-brain axis in Parkinson's disease (PD) may lead to motor symptoms and PD pathogenesis. Recently, the neuroprotective potential of different PPAR delta-agonists has been shown. We aimed to reveal the effects of erucic acid, perox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6001d96d486ec2405bf19964ca322f0c
https://hdl.handle.net/11424/284640
https://hdl.handle.net/11424/284640
Autor:
null İsmail Ünal, null Derya Cansız, null Mustafa Gani Sürmen, null Saime Sürmen, null Zehra Sezer, null Merih Beler, null Ünsal Veli Üstündağ, null Elif Güzel, null A. Ata Alturfan, null Ebru Emekli‐Alturfan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcdcd842ec46a72abf811ed680aeaf23
https://doi.org/10.1111/ejn.15904/v4/response1
https://doi.org/10.1111/ejn.15904/v4/response1
Autor:
Canan Cacina, Soykan Arikan, Saime Sürmen, Roya Mashadiyeva, Nihat Aksakal, Seyda Demirkol, Ilhan Yaylim
Publikováno v:
Turkish Journal of Biochemistry. 48:168-174
Objectives The accumulation of genetic damages in onset of cancer induce activation of protooncogenes or inactivation of tumor suppressor genes thus cause disruption of the balance between cell proliferation and programmed cell death. As a member of
Publikováno v:
The Analyst. 145:7125-7149
Understanding the cellular processes is central to comprehend disease conditions and is also true for cancer research. Proteomic studies provide significant insight into cancer mechanisms and aid in the diagnosis and prognosis of the disease. Phospho
Autor:
Seyda Demirkol, Saime Sürmen, Ozlem Kucukhuseyin, Ayşegül Verim, Cem Horozoglu, Umit Zeybek, Ilhan Yaylim, Dilara Sonmez
Publikováno v:
Türk Biyokimya Dergisi, Vol 46, Iss 6, Pp 703-708 (2021)
Objectives: Genetic variations of LGALS3 (Galectin-3) were found to be associated with treatment resistance, mortality, recurrence, high tumor volume and multiple tumor involvement in solid organ cancers. The modulators of extracellular matrix (ECM),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa5338dacf6d2310debc9d03376b817
https://hdl.handle.net/20.500.12445/2012
https://hdl.handle.net/20.500.12445/2012
Autor:
Mustafa G. Sürmen, Saime Sürmen, Derya Cansız, İsmail Ünal, Ünsal V. Üstündağ, Ahmet A. Alturfan, Derya Büyükkayhan, Ebru Emekli‐Alturfan
Publikováno v:
Journal of biochemical and molecular toxicologyREFERENCES. 36(5)
Rotenone is used to generate Parkinson's disease (PD)-like symptoms in experimental animals. Octanoic acid (C8), is the principal fatty acid of medium-chain triglycerides in ketogenic diets. Beneficial effects of ketogenic diets were shown in PD. We
Autor:
A. Ata Alturfan, Derya Cansız, Saime Sürmen, Ünsal Veli Üstündağ, Mustafa Gani Sürmen, Ebru Emekli-Alturfan, İsmail Ünal
Ketosis is a potentially beneficial metabolic state for health especially in neurological conditions including Parkinson's disease (PD). Medium-chain-triglycerides (MCT) have specific metabolic properties and they are described as ketogenic even with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c368d920e22c5dfac8170f3dfcb16a27
https://hdl.handle.net/20.500.12511/8527
https://hdl.handle.net/20.500.12511/8527
Publikováno v:
Experimed. 81:23-32
DOI: 10.26650/experimed.2018.416075 Proteomik calismalar, kutle spektrometresi ve kromatografi alanindaki teknolojik gelismeler sayesinde patolojik ya da fizyolojik olaylari daha detayli olarak degerlendirebilmemize imkan saglamaktadir. Kutle spektro